InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Higgins Michael J, 董事长兼首席执行官. Officer active across 2 companies, notably Voyager Therapeutics, Inc.. Cumulatively, 3 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €93k. Activity tracked since 13 January 2022. The latest transaction was filed on 25 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Higgins Michael J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
9,090 股@ US$2.75100.0% 占其流量Common StockSEC:0000950170-25-046099:0
13,891 股@ US$6.70100.0% 占其流量Common StockSEC:0001104659-22-080576:0
45,205 股0Common StockSEC:0001104659-22-005020:0
3 条申报中的 3 条
About Higgins Michael J
Michael J. Higgins is the Interim President & CEO of Voyager Therapeutics, Inc. In this role, he oversees the company's operations and leads the overall strategy. His experience in the biopharmaceutical sector is valuable in guiding the firm's research and development initiatives.
